News Headlines Article

FDA to limit access to diabetes drug Avandia
Los Angeles Times

The Food and Drug Administration said Thursday that it would sharply limit access to the diabetes drug Avandia because of concerns that it increases the risk of heart attacks and other cardiovascular problems.

Patients who are now taking the drug will have to sign an informed consent statement acknowledging that they understand all the risks before they will be allowed to refill their prescriptions.